Transplant Glomerulopathy
📧 Sign up to get email alerts when something new happens for Transplant Glomerulopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant [Phase 1, Phase 2]
The trial update reports Phase 1/2 results for clazakizumab in chronic and active antibody-mediated rejection after kidney transplantation, …
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant [Phase 1, Phase 2]
Clinical trial update on clazakizumab for highly HLA-sensitized patients awaiting kidney transplant; the study spans Phase 1/2 with status A…
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar [Phase 4]
Phase 4 trial update on Acthar for treatment of chronic antibody-mediated rejection in kidney transplant patients with transplant glomerulop…
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial update on Acthar as rescue therapy for transplant glomerulopathy in kidney transplant recipients; study terminated wi…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1
The update describes a completed clinical trial on chronic transplant glomerulopathy in kidney transplant recipients. It investigates how Ep…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.